Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Ascendis Pharma A/S changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 160 | 1 | 185 | +26 |
| Shares | 60.3M | 19.3K | 60.3M | +2.42K (0.0%) |
| Value | $5.64B | $1.81M | $7.59B | +$1.95B (+34.5%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (47)
Institutions that held Ascendis Pharma A/S at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (21)
Institutions that held Ascendis Pharma A/S at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Jennison Associates LLC | 159,434 | $14.9M |
| Alyeska Investment Group, L.P. | 112,994 | $10.6M |
| Boxer Capital, LLC | 95,000 | $8.90M |
| Balyasny Asset Management LLC | 94,868 | $8.88M |
| Verition Fund Management LLC | 87,112 | $8.16M |
| Susquehanna International Group, LLP | 19,330 | $1.81M |
| Prudential Financial Inc | 14,000 | $1.33M |
| ExodusPoint Capital Management, LP | 13,743 | $1.29M |
| Duality Advisers, LP | 10,683 | $1.00M |
| Credit Suisse AG | 8,932 | $836.4K |
| Advisors Asset Management, Inc. | 5,519 | $516.8K |
| Tudor Investment Corp Et Al | 3,413 | $319.6K |
| Aquatic Capital Management LLC | 2,800 | $262.0K |
| Cresset Asset Management, LLC | 2,605 | $243.9K |
| XTX Topco Ltd | 2,398 | $224.5K |
| JGP Global Gestao de Recursos Ltda. | 2,305 | $215.8K |
| Private Ocean, LLC | 481 | $45.0K |
| SkyView Investment Advisors, LLC | 228 | $21.0K |
| Cutler Group LP | 200 | $18.0K |
| Macroview Investment Management LLC | 46 | $4.31K |
| Newbridge Financial Services Group, Inc. | 25 | $2.34K |
Not filed for Q4 2023 yet (1)
Institutions that held Ascendis Pharma A/S at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| First Republic Investment Management, Inc. | 19,325 | $1.81M |